|
The company raised its estimate for Medicare Advantage membership but now expects a larger decline in Medicare Advantage prescription drug plan membership and lower commercial enrollment. The company expects a profit of $1.65 to $1.70 per share in the second quarter including the reserve benefit. Analysts forecast $1.47 per share.
[Associated
Press]
Copyright 2010 The Associated Press. All rights reserved. This
material may not be published, broadcast, rewritten or
redistributed.
News | Sports | Business | Rural Review | Teaching & Learning | Home and Family | Tourism | Obituaries
Community |
Perspectives
|
Law & Courts |
Leisure Time
|
Spiritual Life |
Health & Fitness |
Teen Scene
Calendar
|
Letters to the Editor